Evidence map›Paper›PMID 32511596›Full record

ArticlemedRxiv : the preprint server for health sciences2020

Cryptic transmission of SARS-CoV-2 in Washington State.

Trevor Bedford, Alexander L Greninger, Pavitra Roychoudhury, Lea M Starita, Michael Famulare, Meei-Li Huang, Arun Nalla, Gregory Pepper, Adam Reinhardt, Hong Xie and 47 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

57 authors.

Trevor BedfordFred Hutchinson Cancer Research Center, Seattle, WA USA.
Alexander L GreningerFred Hutchinson Cancer Research Center, Seattle, WA USA.
Pavitra RoychoudhuryFred Hutchinson Cancer Research Center, Seattle, WA USA.
Lea M StaritaBrotman Baty Institute for Precision Medicine, Seattle, WA USA.
Michael FamulareInstitute for Disease Modeling, Bellevue, WA USA.
Meei-Li HuangUniversity of Washington, Seattle, WA USA.
Arun NallaUniversity of Washington, Seattle, WA USA.
Gregory PepperUniversity of Washington, Seattle, WA USA.
Adam ReinhardtUniversity of Washington, Seattle, WA USA.
Hong XieUniversity of Washington, Seattle, WA USA.
Lasata ShresthaUniversity of Washington, Seattle, WA USA.
Truong N NguyenUniversity of Washington, Seattle, WA USA.
Amanda AdlerSeattle Children's Research Institute, Seattle, WA USA.
Elisabeth BrandstetterUniversity of Washington, Seattle, WA USA.
Shari ChoUniversity of Washington, Seattle, WA USA.
Danielle GirouxUniversity of Washington, Seattle, WA USA.
Peter D HanUniversity of Washington, Seattle, WA USA.
Kairsten FayFred Hutchinson Cancer Research Center, Seattle, WA USA.
Chris D FrazarUniversity of Washington, Seattle, WA USA.
Misja IlcisinFred Hutchinson Cancer Research Center, Seattle, WA USA.
Kirsten LacombeSeattle Children's Research Institute, Seattle, WA USA.
Jover LeeFred Hutchinson Cancer Research Center, Seattle, WA USA.
Anahita KiavandUniversity of Washington, Seattle, WA USA.
Matthew RichardsonUniversity of Washington, Seattle, WA USA.
Thomas R SibleyFred Hutchinson Cancer Research Center, Seattle, WA USA.
Melissa TruongUniversity of Washington, Seattle, WA USA.
Caitlin R WolfUniversity of Washington, Seattle, WA USA.
Deborah A NickersonBrotman Baty Institute for Precision Medicine, Seattle, WA USA.
Mark J RiederBrotman Baty Institute for Precision Medicine, Seattle, WA USA.
Janet A EnglundUniversity of Washington, Seattle, WA USA.
Seattle Flu Study Investigators
James HadfieldFred Hutchinson Cancer Research Center, Seattle, WA USA.
Emma B HodcroftUniversity of Basel and Swiss Institute of Bioinformatics, Basel, Switzerland.
John HuddlestonFred Hutchinson Cancer Research Center, Seattle, WA USA.
Louise H MonclaFred Hutchinson Cancer Research Center, Seattle, WA USA.
Nicola F MüllerFred Hutchinson Cancer Research Center, Seattle, WA USA.
Richard A NeherUniversity of Basel and Swiss Institute of Bioinformatics, Basel, Switzerland.
Xianding DengUniversity of California San Francisco, San Francisco, CA USA.
Wei GuUniversity of California San Francisco, San Francisco, CA USA.
Scot FedermanUniversity of California San Francisco, San Francisco, CA USA.
Charles ChiuUniversity of California San Francisco, San Francisco, CA USA.
Jeff DuchinUniversity of Washington, Seattle, WA USA.
Romesh GautomWashington State Department of Health, Shoreline, WA USA.
Geoff MellyWashington State Department of Health, Shoreline, WA USA.
Brian HiattWashington State Department of Health, Shoreline, WA USA.
Philip DykemaWashington State Department of Health, Shoreline, WA USA.
Scott LindquistWashington State Department of Health, Shoreline, WA USA.
Krista QueenCenters for Disease Control and Prevention, Atlanta, GA USA.
Ying TaoCenters for Disease Control and Prevention, Atlanta, GA USA.
Anna UeharaCenters for Disease Control and Prevention, Atlanta, GA USA.
Suxiang TongCenters for Disease Control and Prevention, Atlanta, GA USA.
Duncan MacCannellCenters for Disease Control and Prevention, Atlanta, GA USA.
Gregory L ArmstrongCenters for Disease Control and Prevention, Atlanta, GA USA.
Geoffrey S BairdUniversity of Washington, Seattle, WA USA.
Helen Y ChuBrotman Baty Institute for Precision Medicine, Seattle, WA USA.
Jay ShendureBrotman Baty Institute for Precision Medicine, Seattle, WA USA.
Keith R JeromeFred Hutchinson Cancer Research Center, Seattle, WA USA.

Funding

Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigationR35GM119774 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2016 to 2025
$4.1M
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic AcidsK08CA230156 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GU, WEI · 2018 to 2022
$1.4M
Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profilingR21AI129455 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2017 to 2018
$436k
NCI NIH HHS K08 CA230156NIAID NIH HHS R21 AI129455NIGMS NIH HHS R35 GM119774Wellcome Trust
6 · The paper itself

Abstract

Following its emergence in Wuhan, China, in late November or early December 2019, the SARS-CoV-2 virus has rapidly spread throughout the world. On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic. Genome sequencing of SARS-CoV-2 strains allows for the reconstruction of transmission history connecting these infections. Here, we analyze 346 SARS-CoV-2 genomes from samples collected between 20 February and 15 March 2020 from infected patients in Washington State, USA. We found that the large majority of SARS-CoV-2 infections sampled during this time frame appeared to have derived from a single introduction event into the state in late January or early February 2020 and subsequent local spread, strongly suggesting cryptic spread of COVID-19 during the months of January and February 2020, before active community surveillance was implemented. We estimate a common ancestor of this outbreak clade as occurring between 18 January and 9 February 2020. From genomic data, we estimate an exponential doubling between 2.4 and 5.1 days. These results highlight the need for large-scale community surveillance for SARS-CoV-2 introductions and spread and the power of pathogen genomics to inform epidemiological understanding.

Identifiers

PMID32511596
PMCPMC7276023

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.